Participants randomized to retatrutide initiated treatment with 2 mg once-weekly and increased the dose in a step-wise approach every four weeks until reaching the target dose of 4 mg (via one step at 2 mg), 9 mg (via steps at 2 mg, 4 mg and 6 mg) or 12 mg (via steps at 2 mg, 4 mg, 6 mg and 9 mg)
Starting from a baseline that produces minimal effect due to rapid degradation, doubling that baseline still produces minimal effect
It gets worse from there, with victims suffering impaired motor skills, difficulty breathing, even problems with hand-eye coordination and other cognitive disorders
The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey
Only works a few months
NAD+ Injection works by providing additional NAD+ for the bodys cells to be used in metabolic and regulatory processes